Publication: Melatonin and its derivative disrupt cancer stem-like phenotypes of lung cancer cells via AKT downregulation
1
Issued Date
2021-12-01
Resource Type
ISSN
14401681
03051870
03051870
Other identifier(s)
2-s2.0-85113866115
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical and Experimental Pharmacology and Physiology. Vol.48, No.12 (2021), 1712-1723
Suggested Citation
Preeyaporn Plaimee Phiboonchaiyanan, Ploenthip Puthongking, Verisa Chawjarean, Saraporn Harikarnpakdee, Monruedee Sukprasansap, Pithi Chanvorachote, Aroonsri Priprem, Piyarat Govitrapong Melatonin and its derivative disrupt cancer stem-like phenotypes of lung cancer cells via AKT downregulation. Clinical and Experimental Pharmacology and Physiology. Vol.48, No.12 (2021), 1712-1723. doi:10.1111/1440-1681.13572 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/75923
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Melatonin and its derivative disrupt cancer stem-like phenotypes of lung cancer cells via AKT downregulation
Abstract
Cancer stem cells (CSCs), a small subpopulation of tumour cells, have properties of self-renewal and multipotency, which drive cancer progression and resistance to current treatments. Compounds potentially targeting CSCs have been recently developed. This study shows how melatonin, an endogenous hormone synthesised by the pineal gland, and its derivative suppress CSC-like phenotypes of human non-small cell lung cancer (NSCLC) cell lines, H460, H23, and A549. The effects of MLT and its derivative, acetyl melatonin (ACT), on CSC-like phenotypes were investigated using assays for anchorage-independent growth, three-dimensional spheroid formation, scratch wound healing ability, and CSC marker and upstream protein signalling expression. Enriched CSC spheroids were used to confirm the effect of both compounds on lung cancer cells. MLT and ACT inhibited CSC-like behaviours by suppression of colony and spheroid formation in NSCLC cell lines. Their effects on spheroid formation were confirmed in CSC-enriched H460 cells. CSC markers, CD133 and ALDH1A1, were depleted by both compounds. The behaviour and factors associated to epithelial–mesenchymal transition, as indicated by cell migration and the protein vimentin, were also decreased by MLT and ACT. Mechanistically, MLT and ACT decreased the expression of stemness proteins Oct-4, Nanog, and β-catenin by reducing active AKT (phosphorylated AKT). Suppression of the AKT pathway was not mediated through melatonin receptors. This study demonstrates a novel role, and its underlying mechanism, for MLT and its derivative ACT in suppression of CSC-like phenotypes in NSCLC cells, indicating that they are potential candidates for lung cancer treatment.